Suppr超能文献

突触后5-HT1A受体介导8-OH-DPAT对小鼠的抗抑郁样作用。

Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors.

作者信息

Luscombe G P, Martin K F, Hutchins L J, Gosden J, Heal D J

机构信息

Boots Pharmaceuticals Research Department, Nottingham.

出版信息

Br J Pharmacol. 1993 Mar;108(3):669-77. doi: 10.1111/j.1476-5381.1993.tb12859.x.

Abstract
  1. The 5-hydroxytryptamine (5-HT)1A agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH-DPAT) has been evaluated in a mouse model for detecting potential antidepressants (Porsolt test). The effects of various receptor antagonists, lesions of brain monoaminergic neurones and chronic drug treatments on this 8-OH-DPAT-induced response have also been determined. 2. 8-OH-DPAT (0.3-10.0 mg kg-1, s.c.) dose-dependently increased the mobility of mice in the Porsolt test. Other selective 5-HT1A receptor ligands (0.3-30 mg kg-1, s.c.) either mimicked the 8-OH-DPAT response (ipsapirone, at 10 and 30 mg kg-1, s.c.) or were inactive (buspirone and gepirone). However, each of these compounds (< or = 100 mg kg-1, p.o.) inhibited the response to 8-OH-DPAT (3 mg kg-1, s.c.) when given concurrently. 3. The putative 5-HT1A antagonists, spiroxatrine (1-30 mg kg-1, p.o.), (+/-)-pindolol (30 mg kg-1, p.o.) and methiothepin (3-10 mg kg-1, p.o.), each attenuated the 8-OH-DPAT (3 mg kg-1, s.c.)-induced increase in mobility. 4. The dopamine D1 receptor antagonist, SCH 23390 (3-10 mg kg-1, p.o.), weakly reversed the 8-OH-DPAT response. Antagonists at 5-HTlc/5-HT2 receptors (ketanserin; 0.1-3.0 mg kg-1, p.o.),5-HT3 receptors (ondansetron; 0.03-10mg kg-1, p.o.), at-adrenoceptors (prazosin; 1-3mgkg-1, p.o.),alpha2 -adrenoceptors (idazoxan; 3-30mg kg-1, p.o.), alpha 1-adrenoceptors (metoprolol; 1-30mgkg-1, p.o.),beta 2-adrenoceptors (ICI 118,551; 1-30 mg kg-1, p.o.), dopamine D2 receptors (sulpiride; 10-300mg kg-',p.o.) and opiate receptors (naloxone; 3-100 mg kg-', p.o.) had no effect on the 8-OH-DPAT response.5. Selective destruction of 5-HT neurones with 5,7-dihydroxytryptamine or inhibition of 5-HT synthesis with p-chlorophenylalanine did not change the 8-OH-DPAT response in the Porsolt test. This response was also unaltered by pretreatment with the noradrenergic neurotoxin, DSP-4.6. Administration of 8-OH-DPAT (3 mg kg-1, s.c.) twice-daily for 10 days attenuated the hypothermia,but not the increased mobility, induced by 8-OH-DPAT (3 mg kg-1, s.c.). Similarly, repeated administration of amitriptyline (3-30 mg kg-1), desipramine (3-30 mg kg-1) or dothiepin (10-100 mg kg-1) also attenuated the former, but not the latter, response.7. We conclude that 8-OH-DPAT produces an antidepressant-like effect in the Porsolt test which is mediated via postsynaptic 5-HT1A receptors.
摘要
  1. 5-羟色胺(5-HT)1A激动剂8-羟基-2-(二丙基氨基)四氢萘(8-OH-DPAT)已在一种用于检测潜在抗抑郁药的小鼠模型(波索尔特试验)中进行了评估。还确定了各种受体拮抗剂、脑单胺能神经元损伤及慢性药物治疗对这种8-OH-DPAT诱导反应的影响。2. 8-OH-DPAT(0.3 - 10.0毫克/千克,皮下注射)在波索尔特试验中剂量依赖性地增加了小鼠的活动能力。其他选择性5-HT1A受体配体(0.3 - 30毫克/千克,皮下注射)要么模拟了8-OH-DPAT反应(ipsapirone,10和30毫克/千克,皮下注射时),要么无活性(丁螺环酮和吉哌隆)。然而,当同时给予这些化合物(口服,≤100毫克/千克)时,每种化合物都抑制了对8-OH-DPAT(3毫克/千克,皮下注射)的反应。3. 假定的5-HT1A拮抗剂,螺沙群(1 - 30毫克/千克,口服)、(±)-吲哚洛尔(30毫克/千克口服)和甲硫哒嗪(3 - 10毫克/千克,口服),每种都减弱了8-OH-DPAT(3毫克/千克,皮下注射)诱导的活动能力增加。4. 多巴胺D1受体拮抗剂SCH 23390(3 - 10毫克/千克,口服)微弱地逆转了8-OH-DPAT反应。5-HTlc/5-HT2受体拮抗剂(酮色林;0.1 - 3.0毫克/千克,口服)、5-HT3受体拮抗剂(昂丹司琼;0.03 - 10毫克/千克,口服)、α-肾上腺素能受体拮抗剂(哌唑嗪;1 - 3毫克/千克,口服)、α2-肾上腺素能受体拮抗剂(伊达唑啉;3 - 30毫克/千克,口服)、α1-肾上腺素能受体拮抗剂(美托洛尔;1 - 30毫克/千克,口服)、β2-肾上腺素能受体拮抗剂(ICI 118,551;1 - 30毫克/千克,口服)、多巴胺D2受体拮抗剂(舒必利;10 - 300毫克/千克,口服)和阿片受体拮抗剂(纳洛酮;3 - 100毫克/千克,口服)对8-OH-DPAT反应均无影响。5. 用5,7-二羟基色胺选择性破坏5-HT神经元或用对氯苯丙氨酸抑制5-HT合成,在波索尔特试验中并未改变8-OH-DPAT反应。用去甲肾上腺素能神经毒素DSP-4预处理也未改变这种反应。6. 每天两次给予8-OH-DPAT(3毫克/千克,皮下注射),持续10天,减弱了由8-OH-DPAT(3毫克/千克,皮下注射)诱导的体温过低,但未减弱活动能力增加。同样,重复给予阿米替林(3 - 30毫克/千克)、地昔帕明(3 - 30毫克/千克)或多塞平(10 - 100毫克/千克)也减弱了前者而非后者的反应。7. 我们得出结论,8-OH-DPAT在波索尔特试验中产生一种类似抗抑郁药的作用,该作用是通过突触后5-HT1A受体介导的。

相似文献

引用本文的文献

本文引用的文献

1
SPIROXAMIDE (R 5188): A NEW COMPOUND PRODUCING MORPHINE-LIKE AND CHLORPROMAZINE-LIKE EFFECTS IN ANIMALS.
Int J Neuropharmacol. 1963 Dec;2:349-54. doi: 10.1016/0028-3908(63)90010-8.
10
Spiroxatrine: a selective serotonin1A receptor antagonist.螺沙群:一种选择性5-羟色胺1A受体拮抗剂。
Eur J Pharmacol. 1986 May 13;124(1-2):207-8. doi: 10.1016/0014-2999(86)90147-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验